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The protein tyrosine phosphatase SHP-1 regulates integrin-
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Tamara I.A. Roach*, Suzanne E. Slater*, Lynn S. White†, Xiaoling Zhang‡, 
Philip W. Majerus‡, Eric J. Brown* and Matthew L. Thomas†
The Src homology 2 domain phosphatase-1 (SHP-1) is a
tyrosine phosphatase containing two amino-terminal
SH2 domains and is expressed primarily by
hematopoietic-derived cells [1]. The viable motheaten
(Hcphme-v) mutant mice (mev) suffer from progressive
inflammation due to a deficiency of SHP-1 enzyme
activity [2,3] and die at 3–4 months of age from
macrophage and neutrophil accumulation in the lung
[4]. The mechanism by which SHP-1 deficiency leads to
inflammation is unknown. We found that macrophages
from mev mice adhered and spread to a greater extent
than normal macrophages through amb2 integrin-
mediated contacts. Whereas macrophages deficient in
the transmembrane tyrosine phosphatase CD45
(CD45–/–) spontaneously detached from amb2 integrin
contacts [5], cells deficient in both CD45 and SHP-1 did
not. In SHP-1-deficient macrophages there was a
10–15-fold increase in D-3 phospholipid products of
phosphatidylinositol (PI) 3-kinase. Concomitantly, there
was a 2–5-fold increase in membrane-associated PI 
3-kinase activity in mev macrophages relative to normal
macrophages. Treatment of macrophages with the PI 
3-kinase inhibitors wortmannin or LY294002 resulted in
a dramatic detachment of cells, indicating that PI 
3-kinase activity is required for adhesion. These data
demonstrate that SHP-1 is necessary for detachment
from amb2 integrin-mediated contacts in primary
macrophages and suggest that a defect in this pathway
may contribute to inflammatory disease.
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Results and discussion
To investigate whether SHP-1 can regulate αmβ2 integrin-
mediated adhesion, bone marrow derived macrophages
from normal, CD45–/–, mev mice or mice deficient in both
CD45 and SHP-1 (CDm) were replated and allowed to re-
adhere, an event dependent upon αmβ2 integrin adhesion
[5,6]. After 24 hours, the majority of mature macrophages
from normal mice were adherent; however, a substantial
fraction were refractile with minimal spreading (Figure 1a).
As we reported previously [5], CD45-deficient macrophages
were almost entirely detached due to accelerated de-adhe-
sion (Figure 1a). In contrast, macrophages from both mev
and CDm mice were adherent and markedly spread
(Figure 1a). Quantitation of adherent cell areas of single
cells plated at low density revealed that CD45-deficient
macrophages were significantly less spread than normal
macrophages (Figure 1b). However, both mev and CDm cells
showed significantly increased adhesion and spreading
when compared with normal macrophages (Figure 1b). This
demonstrates that catalytically active SHP-1 is required for
the previously reported spontaneous de-adhesion observed
in CD45-deficient macrophages [5]. Compared with normal
macrophages, it is likely that the increased spreading in mev
and CDm macrophages reflects perturbation of a dynamic
balance between adhesion and de-adhesion which requires
SHP-1. Furthermore, the data suggest that SHP-1 phos-
phatase activity is necessary for and downstream of CD45’s
regulation of adhesion.
The p85/p110 PI 3-kinase can be activated by integrin adhe-
sion [7–9] and can regulate cytoskeletal rearrangement con-
trolling cell spreading and adhesion [10,11]. The PI D-3
lipids, PI 3,4-bisphosphate, (PI(3,4)P2) and PI 3,4,5-trisphos-
phate (PI(3,4,5)P3) are the main products of PI 3-kinase acti-
vation in vivo [12]. Hence, to determine whether PI 3-kinase
activity was deregulated in the absence of catalytically active
SHP-1, we examined levels of PI lipids produced by adher-
ent normal, CD45-deficient, mev and CDm macrophages fol-
lowing metabolic labeling of cells with 32[Pi]. When
normalized to total phospholipid content, mev and CDm
macrophages exhibited more than 10–15-fold higher levels
of D-3 phospholipids (Figure 2a), indicating a higher level of
PI 3-kinase activity at the membrane. This was not due to
different expression patterns of the p110α, β or γ subunits in
the macrophages of different genotypes (data not shown). In
contrast, levels of PI and PI(4,5)P2 were similar to normal in
mev and CDm macrophages (Figure 2).
To determine whether the increased adhesion and spreading
observed in mev or CDm macrophages was dependent upon
PI 3-kinase activity, macrophages were treated with wort-
mannin, an inhibitor of PI 3-kinase [13] (Figure 3a). Low
concentrations of wortmannin (20 nM) led to de-adhesion of
macrophages of all genotypes within 1 hour (Figure 3a and
data not shown). LY294002, a PI 3-kinase inhibitor with a
mode of action distinct from that of wortmannin [14], also
induced de-adhesion at 20 µM (data not shown). These data
show that maintenance of PI 3-kinase activity is required for
continued macrophage adhesion and support the conclusion
that SHP-1 regulation of PI 3-kinase is important for its
modulation of macrophage adhesion and spreading.
Membrane localization of PI 3-kinase is required for
enzyme activity because translocation of PI 3-kinase
allows access to phospholipid substrate, and interactions of
the p85 regulatory subunit with other proteins may regu-
late a conformational activation of the p110 catalytic
subunit [12,15]. PI 3-kinase immunoprecipitated (by anti-
p85) from normal and mev whole-cell lysates showed
similar activities in in vitro assays (data not shown).
However, fractionation of the cells into membrane and
cytosol and immunoprecipitation with anti-p85 revealed
that mev macrophages had a 2–5-fold increase in the pro-
portion of PI 3-kinase activity associated with membranes
(Figure 3b and data not shown).
The mev disease is characterized by excessive idiopathic
inflammation as well as increased production of myeloid
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Figure 2
Increase in PI 3-kinase activity in mev macrophages in vivo correlates
with increased adhesion. PI D-3 lipids are elevated in bone marrow
derived macrophages from either mev, or CD45–/– mev (CDm) mice.
Bone marrow derived macrophages from either normal (WT), CD45–/–,
mev or CDm were metabolically labeled with 32[Pi] for 4 h, lysed in
acid and the lipids extracted. Lipids were separated by column
chromatography and normalized to total organic phosphate. The
results of two experiments are shown. Abbreviations: gPI,
glycerophosphoinositol monophosphate; gPI(34)P2,
glycerophosphoinositol 3,4-bisphosphate; gPI(45)P2,
glycerophosphoinositol 4,5-bisphosphate; gPI(343)P3,
glycerophosphoinositol 3,4,5-trisphosphate. 
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Figure 1
Adhesion of bone marrow derived macrophages from normal (+/+,
WT), CD45-deficient (CD45–/–), mev, or CD45–/– mev (CDm) mice to
αmβ2 ligand. (a) Mature bone marrow derived macrophage cultures
were harvested (PBS–10 mM EDTA) and allowed to re-adhere in
medium on non-tissue culture plastic, an αmβ2 ligand [5,6], for 24 h.
Photographs were taken at magnification 320 ×, scanned into Adobe
photoshop 3.0 (Adobe Systems) at 300 dots per inch, and cell area
quantitated using Image Pro Plus (Media Cybernetics).
(b) Quantitation of macrophage adhesion per area of cell spread.
Macrophages were harvested from adherent cultures using
PBS–10 mM EDTA and allowed to re-adhere at low density in medium
for 24 h. Columns in (b) show means ± SEM; numbers of cells
measured were 149, 46, 98 and 93 for WT, CD45–/–, mev and CDm,
respectively. CD45–/–, mev and CDm cell areas were all significantly
different from WT (Student’s t test, p < 0.05).
(a)
CD45–/–+/+
mev/mev, CD45–/–mev/mev
14000
  Current Biology
(b)
12000
10000
8000
6000
4000
2000
0
W
T
CD
45
–/
–
me
v
me
v , C
D4
5–
/–

(C
Dm
)
M
ea
n 
ce
ll 
ar
ea
 (p
ix
el
s)
cells, including extramedullary hematopoiesis. The unreg-
ulated inflammation leads to skin disease, arthritis and
pneumonitis, eventually ending in death of the animal.
Inflammation can be inhibited by blocking αmβ2, the pre-
dominant myeloid integrin, suggesting that regulation of
adhesion has a prominent role in mev disease [16]. We
found that deficiency of SHP-1 induces enhanced αmβ2-
mediated adhesion, regardless of whether or not CD45 is
expressed by the macrophages. The spontaneous detach-
ment from αmβ2-mediated contacts that occurs to some
extent in normal macrophages, and is dramatically
increased in the absence of CD45, is abrogated by a defi-
ciency of SHP-1. As mev mice express a catalytically
impaired SHP-1 protein, this finding demonstrates that
SHP-1 phosphatase activity is required for normal regula-
tion of macrophage de-adhesion.
The mechanism by which SHP-1 activates de-adhesion
probably requires that it regulate PI 3-kinase. The mev and
CDm macrophages have markedly increased D-3 phospho-
lipid levels, indicating enhanced PI 3-kinase activity in
vivo, and PI 3-kinase inhibitors cause detachment of
normal and SHP-1-deficient macrophages from αmβ2-
integrin-mediated contacts. Because total cellular PI 3-
kinase activity is not affected by SHP-1 deficiency, but
membrane-associated PI 3-kinase is markedly increased in
its absence, it is specifically the membrane-associated pool
of PI 3-kinase which is regulated by SHP-1. Although this
is a minority of whole-cell PI 3-kinase protein, it is proba-
bly the physiologically important pool of enzyme as it is
associated with substrate.
Mice deficient in the SH2-containing inositol phosphatase
SHIP have a remarkably similar phenotype to mev mice,
with an accumulation of macrophages and neutrophils in
the lung and a shortened life span [17]. It has been shown
in cell lines that inhibitory signaling following specific
receptor recruitment of SHIP or SHP-1 can function via
independent receptor pathways [18]. Our data suggest
that SHP-1 regulates the level of PI D-3 lipids through the
control of PI-3 kinase activation. Thus, pathways inhib-
ited by SHP-1 and SHIP may converge at the level of reg-
ulation of phosphorylated phosphatidylinositol lipids. The
similar phenotypes of mev mice and SHIP-deficient mice
suggest that it is deregulation of phosphatidylinositol
phosphorylation that contributes significantly to the idio-
pathic inflammation in both mouse strains.
CD45 and SHP-1 have been proposed to have opposing
effects on lymphocyte activation [19]. If the same were
true for myeloid activation, or if the inflammatory disease
of mev mice was due to a primary abnormality in lympho-
cyte signaling, CD45 deficiency should ameliorate the
disease of mev mice. However, CDm mice present a disease
pathology indistinguishable from that of mev mice, with
involvement of skin, thymus, spleen, kidney and lungs
(unpublished observations). Together with data demon-
strating that a blockade of αmβ2 interaction slows the mev
disease in a bone marrow chimeric model [16], these data
strongly suggest that the failure to regulate macrophage de-
adhesion normally may be critical for the spontaneous
inflammation that characterizes the mev disease. We
propose that the pathologic accumulation of leukocytes in
lung and other tissues of mev and CDm mice results in part
from the failure to properly regulate leukocyte de-adhe-
sion. Normal migration of phagocytes into tissues is accom-
panied by integrin activation and enhanced adhesion, a
reversible process [20–22]. After migration of macrophages
out of the vasculature and into tissue at sites of inflamma-
tion, the regulation of macrophage adhesion is likely to be
key to the control of macrophage survival and activation at
these sites. The failure of mev and CDm macrophages to
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Figure 3
PI 3-kinase activity is required for integrin-
mediated adhesion in macrophages and is
increased in the membrane fraction of cells.
(a) CDm bone marrow derived macrophages
before (top) and after (bottom) treatment with
wortmannin. Adherent macrophages were
treated for 20 min with 20 nM wortmannin at
37°C. Magnification is 320 ×. Similar results
were obtained for macrophages from the
other genotypes. The PI 3-kinase inhibitor
LY294002 (20 µM) caused a similar rounding
and detachment of cells. (b) PI 3-kinase was
immunoprecipitated from membrane and
cytosol fractions of wild-type (WT) and mev
macrophages (1 × 107 cells) with anti-p85
antisera and its activity assayed in vitro. 32[Pi]
activity incorporated into the PI substrate by
PI 3-kinase was quantitated by
phosphorimage analysis after thin-layer
chromatography separation of lipids. 
PI 3-kinase activity in the membrane fraction
relative to total cell activity for WT and mev
macrophages was 1.83% and 9.84%,
respectively.
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regulate adhesion and spreading appropriately, as shown in
our in vitro studies, and the hyperactivation of PI 3-kinase,
could be central to the in vivo accumulation of
macrophages in tissue in SHP-1-deficient mice [23]. In
conclusion, these studies have elucidated a novel function
for SHP-1 — the regulation of integrin-mediated adhesion
through regulation of the function of PI 3-kinase. Patho-
logic deregulation of this interaction leads to inflammation
and is a likely biochemical target for intervention to control
the idiopathic and excessive inflammation that character-
izes human autoimmune diseases.
Supplementary material
Additional methodological details are published with this paper on 
the internet.
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Materials and methods
Mice
All mice were maintained according to NIH guidelines in a specific
pathogen-free barrier facility. Breeding pairs of mev mice were purchased
from Jackson Laboratory and maintained in our facility for greater than
3 years by crossing heterozygous pairs. The presence of the mev allele
was determined by PCR as previously described [S1]. The derivation of
the CD45-deficient animals has been described previously [S2]. CD45-
deficient mice were backcrossed to B6 mice for at least nine generations
and maintained as homozygous mice. To generate mice deficient in both
SHP-1 and CD45, mev mice were crossed to CD45-deficient mice to
generate mice heterozygous for each allele. Doubly heterozygous mice
were crossed to CD45–/– mice to generate mice that were heterozygous
for the mev allele and homozygous for the CD45-gene targeted allele.
CDm mice were generated by crossing heterozygous mev, CD45–/–
mice. Mice were from 4 to 12 weeks of age, and were sex- and age-
matched (within 2 weeks of age) within experiments.
Adhesion
Macrophages were differentiated from bone marrow precursors and
maintained in culture as previously described [5]. Briefly, bone marrow
derived macrophages were differentiated from promonocytes plated at
5 × 108 to 1 × 107 cells per dish on non-tissue culture treated plastic
(Valmark ‘ultradish’, Midwest Scientific) in high-glucose Dulbecco’s
modified Eagle’s medium (DMEM; Gibco-BRL), with 10% fetal bovine
serum (FBS; HyClone Labs), 20 mM HEPES, and 15% L929 cell-con-
ditioned supernatant as a source of M-CSF. Mature bone marrow
macrophages were harvested from day 6 to day 15 in PBS containing
10 mM EDTA. Wortmannin and LY294002 were dissolved in DMSO
and used at final concentrations of 1–20 nM or 5–20 µM, respectively.
Immunoprecipitations and kinase reactions
Macrophages, 3–8 × 106 cells per point, were lysed in ice cold Tris-
buffered saline (150 mM NaCl, 50 mM Tris-HCl pH 7.5) containing 1%
Triton X-100 (Pierce), 1% deoxycholate, 1 mM EDTA (lysis buffer), with
10 µg/ml leupeptin, 10 µg/ml aprotinin, 1 mM NaF, 200 µM pervana-
date and 2 mM diisopropyl-fluorophosphate (all chemicals from Sigma).
Nuclei and debris were removed by centrifugation and supernatants
collected. Lysates were precleared with protein A (or G)–Sepharose
coupled to normal rabbit IgG or whole serum. Immunoprecipitations
were performed using protein A/G coupled to rabbit IgG against SHP-
1 or whole rabbit serum anti-p85 (#06-195, UBI) or SHP-1 [S3].
Immunoprecipitates collected by centrifugation were washed three
times in lysis buffer with inhibitors and resolved by SDS–PAGE.
Kinase activity of immunoprecipitated p85 was determined by an in vitro
kinase assay using phosphotidylinositol as substrate (Sigma or Avanti
Polar Lipids). After washing (twice in 10 mM Tris pH 7.5/150 mM
NaCl/1% Triton X-100, twice in 10 mM Tris pH 7.5/0.5 M LiCl, twice in
PI 3-kinase reaction buffer; see below), p85 was resuspended in PI 3-
kinase reaction buffer (20 mM HEPES pH 7.4, 0.4 mM EGTA, 10 mM
MgCl2, 100 µM pervanadate) with PI substrate. To initiate the kinase
reaction 10 µCi [γ-32P]ATP (4500 Ci/mM, ICN Biomedicals) and unla-
beled ATP (20 µM final concentration) were added. Reactions were
stopped by adding 80 µl 1N HCl and 160 µl chloroform:methanol (1:1).
Lipids were extracted twice, then resolved on thin-layer chromatography
plates (Whatman) coated with potassium oxalate.
Analysis of D-3 phosphate-containing inositol phospholipids
Differentiated macrophages were labeled with 1 mCi/ml 32[Pi]
(400–800 µCi/ml, HCl free (ICN Biomedicals) in phosphate-free
DMEM, 5% fetal calf serum for 4 h at 37°C. D-3 phosphate-containing
inositol phospholipids were analyzed as previously described [S4].
Briefly, monolayers were lysed in 1 M perchloric acid and lipids
extracted with CHCl3 : methanol (1:2, v/v) and deacylated with methy-
lamine. Glycerophospholipids were separated by HPLC using a Parsil
10 Sax column (Whatman) [S5]. [3H]inositol 1-monophosphate,
[3H]inositol 1,4-bisphosphate, and [3H]inositol 1,3,4-trisphosphate
were used as internal standards in HPLC. [32P]3-phosphate-containing
glycerophosphoinositols, [32P]gPI 3-P, [32P]gPI 3,4-P2, [32P]gPI 3,4,5-
P3 were prepared as described [S6], chromatographed separately and
used to identify specific glycerophosphoinositols.
Membrane/cytosol fractionation
Macrophages were washed and resuspended in ice cold sonication
buffer (20 mM HEPES pH 7.4, 0.5 mM pervanadate, 1 mM DFP,
0.5 mM NaF, 10 µg/ml leupeptin/aprotinin, 1 mM pepstatin A). Cells
were sonicated on ice using a sonication probe (Vibra cell, Sonics and
Materials). Nuclei and coarse debris were removed by centrifugation
(650 g, 15 min). Supernatants were collected and centrifuged at
100,000 g (1 h) to separate membrane/cytoskeleton from cytosol.
Membrane fractions were resolubilized in 1% Triton X-100/1% deoxy-
cholate plus inhibitors in lysis buffer (see above) and sonicated, insolu-
ble matter was removed by centrifugation (15,000 g, 10 min).
Detergents and NaCl were added to cytosol preparations at equivalent
concentrations for immunoprecipitations.
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